Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis

Growth Hormone and IGF Research

Volumn 34, Issue , 2017, Pages 13-21

  Raisingani, Manish ^a   Preneet, Brar ^a   Kohn, Brenda ^a   Yakar, Shoshana ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

Bone mineral density (BMD); Growth hormone (GH); Growth velocity; Insulin like growth factor 1 (IGF 1); Type 1 diabetes mellitus (T1DM)

Indexed keywords

GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; SCLEROSTIN; SOMATOMEDIN C; VITAMIN D; HUMAN GROWTH HORMONE; IGF1 PROTEIN, HUMAN;

ADOLESCENCE; BODY HEIGHT; BONE DENSITY; BONE GROWTH; BONE MARROW; BONE MASS; BONE METABOLISM; BONE MINERAL; CHILD; CHILDHOOD DISEASE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GROWTH HORMONE RELEASE; GROWTH RATE; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; REVIEW; VITAMIN D DEFICIENCY; ADOLESCENT; ADULT; BONE; BONE DEVELOPMENT; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CHILD; DIABETES MELLITUS, TYPE 1; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 85018351007     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2017.04.003     Document Type: Review

References (127)

1. [1] Vranic, M., Identification of some issues and questions to be answered in comparing type I and type II diabetes. Adv. Exp. Med. Biol. 189 (1985), 1–15.
2. [2] Pan, H., Wu, N., Yang, T., He, W., Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes Metab. Res. Rev. 30 (2014), 531–542.
3. [3] Secrest, A.M., Becker, D.J., Kelsey, S.F., Laporte, R.E., Orchard, T.J., Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 59 (2010), 3216–3222.
4. [4] Hourd, P., Edge, J.A., Dunger, D.B., Dalton, N., Edwards, R., Urinary growth hormone excretion during puberty in type 1 (insulin-dependent) diabetes mellitus. Diabet. Med. 8 (1991), 237–242.
5. [5] Edge, J.A., Dunger, D.B., Matthews, D.R., Gilbert, J.P., Smith, C.P., Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J. Clin. Endocrinol. Metab. 71 (1990), 1356–1362.
6. [6] Salardi, S., Cacciari, E., Pascucci, M.G., Giambiasi, E., Tacconi, M., Tazzari, R., Cicognani, A., Boriani, F., Puglioli, R., Mantovani, W. et al., Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone. Acta Paediatr. Scand. 79 (1990), 437–443.
7. [7] Edge, J.A., Hourd, P., Edwards, R., Dunger, D.B., Urinary growth hormone during puberty in normal and diabetic children. Clin. Endocrinol. 30 (1989), 413–420.
8. [8] Bideci, A., Camurdan, M.O., Cinaz, P., Dursun, H., Demirel, F., Serum zinc, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 18 (2005), 1007–1011.
9. [9] Cianfarani, S., Bonfanti, R., Bitti, M.L., Germani, D., Boemi, S., Chiumello, G., Boscherini, B., Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum. J. Clin. Endocrinol. Metab. 85 (2000), 4162–4167.
10. [10] Radetti, G., Paganini, C., Antoniazzi, F., Pasquino, B., Valentini, R., Gentili, L., Tato, L., Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus. Horm. Res. 47 (1997), 110–115.
11. [11] Munoz, M.T., Barrios, V., Pozo, J., Argente, J., Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pediatr. Res. 39 (1996), 992–998.
12. [12] Bloch, C.A., Clemons, P., Sperling, M.A., Puberty decreases insulin sensitivity. J. Pediatr. 110 (1987), 481–487.
13. [13] Asplin, C.M., Faria, A.C., Carlsen, E.C., Vaccaro, V.A., Barr, R.E., Iranmanesh, A., Lee, M.M., Veldhuis, J.D., Evans, W.S., Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 69 (1989), 239–245.
14. [14] Daughaday, W.H., Phillips, L.S., Mueller, M.C., The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology 98 (1976), 1214–1219.
15. [15] Ekstrom, K., Salemyr, J., Zachrisson, I., Carlsson-Skwirut, C., Ortqvist, E., Bang, P., Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes. Diabetes Care 30 (2007), 1357–1363.
16. [16] Van Sickle, B.J., Simmons, J., Hall, R., Raines, M., Ness, K., Spagnoli, A., Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus. Cytokine 48 (2009), 290–294.
17. [17] Jin, Y., Sharma, A., Carey, C., Hopkins, D., Wang, X., Robertson, D.G., Bode, B., Anderson, S.W., Reed, J.C., Steed, R.D., Steed, L., She, J.X., The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes. Diabetes Care 36 (2013), 2794–2802.
18. [18] Rogers, D.G., Sherman, L.D., Gabbay, K.H., Effect of puberty on insulinlike growth factor I and HbA1 in type I diabetes. Diabetes Care 14 (1991), 1031–1035.
19. [19] Dills, D.G., Allen, C., Palta, M., Zaccaro, D.J., Klein, R., D'Alessio, D., Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 80 (1995), 2139–2143.
20. [20] Sharma, A., Purohit, S., Sharma, S., Bai, S., Zhi, W., Ponny, S.R., Hopkins, D., Steed, L., Bode, B., Anderson, S.W., She, J.X., IGF-binding proteins in type-1 diabetes are more severely altered in the presence of complications. Front Endocrinol (Lausanne), 7, 2016, 2.
21. [21] Bereket, A., Lang, C.H., Blethen, S.L., Ng, L.C., Wilson, T.A., Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children. Clin. Endocrinol. 45 (1996), 321–326.
22. [22] Batch, J.A., Baxter, R.C., Werther, G., Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 73 (1991), 964–968.
23. [23] Onder, A., Cetinkaya, S., Tunc, O., Aycan, Z., Evaluation of bone mineral density in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 26 (2013), 1077–1081.
24. [24] Du Caju, M.V., Rooman, R.P., op de Beeck, L., Longitudinal data on growth and final height in diabetic children. Pediatr. Res. 38 (1995), 607–611.
25. [25] Vanelli, M., de Fanti, A., Adinolfi, B., Ghizzoni, L., Clinical data regarding the growth of diabetic children. Horm. Res. 37:Suppl. 3 (1992), 65–69.
26. [26] Saha, M.T., Sievanen, H., Salo, M.K., Tulokas, S., Saha, H.H., Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos. Int. 20 (2009), 1401–1406.
27. [27] Mahesh, S., Karp, R.J., Castells, S., Quintos, J.B., Mauriac syndrome in a 3-year-old boy. Endocr. Pract. 13 (2007), 63–66.
28. [28] Loureiro, M.B., Ururahy, M.A., Freire-Neto, F.P., Oliveira, G.H., Duarte, V.M., Luchessi, A.D., Brandao-Neto, J., Hirata, R.D., Hirata, M.H., Maciel-Neto, J.J., Arrais, R.F., Almeida, M.G., Rezende, A.A., Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. Diabetes Res. Clin. Pract. 103 (2014), 452–457.
29. [29] Salerno, M., Argenziano, A., Di Maio, S., Gasparini, N., Formicola, S., De Filippo, G., Tenore, A., Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 20 (1997), 721–724.
30. [30] Brown, M., Ahmed, M.L., Clayton, K.L., Dunger, D.B., Growth during childhood and final height in type 1 diabetes. Diabet. Med. 11 (1994), 182–187.
31. [31] Yakar, S., Isaksson, O., Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: lessons from mouse models. Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society 28 (2016), 26–42.
32. [32] Hypponen, E., Virtanen, S.M., Kenward, M.G., Knip, M., Akerblom, H.K., Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 23 (2000), 1755–1760.
33. [33] Domargard, A., Sarnblad, S., Kroon, M., Karlsson, I., Skeppner, G., Aman, J., Increased prevalence of overweight in adolescent girls with type 1 diabetes mellitus. Acta Paediatr. 88 (1999), 1223–1228.
34. [34] Hypponen, E., Kenward, M.G., Virtanen, S.M., Piitulainen, A., Virta-Autio, P., Tuomilehto, J., Knip, M., Akerblom, H.K., Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood diabetes in Finland (DiMe) study group. Diabetes Care 22 (1999), 1961–1965.
35. [35] Johansson, C., Samuelsson, U., Ludvigsson, J., A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37 (1994), 91–94.
36. [36] Baum, J.D., Ounsted, M., Smith, M.A., Letter: weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet, 2, 1975, 866.
37. [37] Songer, T.J., LaPorte, R.E., Tajima, N., Orchard, T.J., Rabin, B.S., Eberhardt, M.S., Dorman, J.S., Cruickshanks, K.J., Cavender, D.E., Becker, D.J. et al., Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members. Br. Med. J. (Clin. Res. Ed.) 292 (1986), 1419–1422.
38. [38] Leger, J., Marinovic, D., Alberti, C., Dorgeret, S., Chevenne, D., Marchal, C.L., Tubiana-Rufi, N., Sebag, G., Czernichow, P., Lower bone mineral content in children with type 1 diabetes mellitus is linked to female sex, low insulin-like growth factor type I levels, and high insulin requirement. J. Clin. Endocrinol. Metab. 91 (2006), 3947–3953.
39. [39] Ahmed, M.L., Connors, M.H., Drayer, N.M., Jones, J.S., Dunger, D.B., Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age. Diabetes Care 21 (1998), 831–835.
40. [40] Massa, G., Dooms, L., Bouillon, R., Vanderschueren-Lodeweyckx, M., Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993), 239–243.
41. [41] Bonfig, W., Kapellen, T., Dost, A., Fritsch, M., Rohrer, T., Wolf, J., Holl, R.W., Growth in children and adolescents with type 1 diabetes. J. Pediatr., 160(900–903), 2012, e902.
42. [42] Parthasarathy, L., Khadilkar, V., Chiplonkar, S., Khadilkar, A., Longitudinal growth in children and adolescents with type 1 diabetes. Indian Pediatr. 53 (2016), 990–992.
43. [43] Galluzzi, F., Stagi, S., Salti, R., Toni, S., Piscitelli, E., Simonini, G., Falcini, F., Chiarelli, F., Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. Eur. J. Endocrinol. 153 (2005), 879–885.
44. [44] Heap, J., Murray, M.A., Miller, S.C., Jalili, T., Moyer-Mileur, L.J., Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitus. J. Pediatr. 144 (2004), 56–62.
45. [45] Gunczler, P., Lanes, R., Paoli, M., Martinis, R., Villaroel, O., Weisinger, J.R., Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 14 (2001), 525–528.
46. [46] Vina Simon, E., Bueno Lozano, G., Armada Maresca, M.I., Ruibal Francisco, J.L., Fernandez Perez, C., Lozano Tonkin, C., Casado de Frias, E., Bone mineral density in juvenile-onset diabetes mellitus. Anales espanoles de pediatria 52 (2000), 507–515.
47. [47] Campos Pastor, M.M., Lopez-Ibarra, P.J., Escobar-Jimenez, F., Serrano Pardo, M.D., Garcia-Cervigon, A.G., Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos. Int. 11 (2000), 455–459.
48. [48] Kemink, S.A., Hermus, A.R., Swinkels, L.M., Lutterman, J.A., Smals, A.G., Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Investig. 23 (2000), 295–303.
49. [49] Weber, D.R., Haynes, K., Leonard, M.B., Willi, S.M., Denburg, M.R., Response to comment on Weber et al. type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 2015;38:1913-1920. Diabetes Care 38 (2015), e205–e206.
50. [50] Liao, C.C., Lin, C.S., Shih, C.C., Yeh, C.C., Chang, Y.C., Lee, Y.W., Chen, T.L., Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37 (2014), 2246–2252.
51. [51] Levin, M.E., Boisseau, V.C., Avioli, L.V., Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med. 294 (1976), 241–245.
52. [52] Wiske, P.S., Wentworth, S.M., Norton, J.A. Jr., Epstein, S., Johnston, C.C. Jr., Evaluation of bone mass and growth in young diabetics. Metab. Clin. Exp. 31 (1982), 848–854.
53. [53] Rosenbloom, A.L., Lezotte, D.C., Weber, F.T., Gudat, J., Heller, D.R., Weber, M.L., Klein, S., Kennedy, B.B., Diminution of bone mass in childhood diabetes. Diabetes 26 (1977), 1052–1055.
54. [54] de Souza, K.S., Ururahy, M.A., da Costa Oliveira, Y.M., Loureiro, M.B., da Silva, H.P., Bortolin, R.H., Melo Dos Santos, F., Luchessi, A.D., Neto, J.J., Arrais, R.F., Hirata, R.D., das Gracas Almeida, M., Hirata, M. H., and de Rezende, A. A., Low bone mineral density in patients with type 1 diabetes: association with reduced expression of IGF1, IGF1R and TGF B 1 in peripheral blood mononuclear cells. Diabetes Metab. Res. Rev. 32 (2016), 589–595.
55. [55] Valerio, G., del Puente, A., Esposito-del Puente, A., Buono, P., Mozzillo, E., Franzese, A., The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm. Res. 58 (2002), 266–272.
56. [56] Moyer-Mileur, L.J., Dixon, S.B., Quick, J.L., Askew, E.W., Murray, M.A., Bone mineral acquisition in adolescents with type 1 diabetes. J. Pediatr. 145 (2004), 662–669.
57. [57] De Schepper, J., Smitz, J., Rosseneu, S., Bollen, P., Louis, O., Lumbar spine bone mineral density in diabetic children with recent onset. Horm. Res. 50 (1998), 193–196.
58. [58] Pascual, J., Argente, J., Lopez, M.B., Munoz, M., Martinez, G., Vazquez, M.A., Jodar, E., Perez-Cano, R., Hawkins, F., Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onset. Calcif. Tissue Int. 62 (1998), 31–35.
59. [59] Ponder, S.W., McCormick, D.P., Fawcett, H.D., Tran, A.D., Ogelsby, G.W., Brouhard, B.H., Travis, L.B., Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus. J. Pediatr. 120 (1992), 541–545.
60. [60] Roe, T.F., Mora, S., Costin, G., Kaufman, F., Carlson, M.E., Gilsanz, V., Vertebral bone density in insulin-dependent diabetic children. Metab. Clin. Exp. 40 (1991), 967–971.
61. [61] Shanbhogue, V.V., Hansen, S., Frost, M., Jorgensen, N.R., Hermann, A.P., Henriksen, J.E., Brixen, K., Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 30 (2015), 2188–2199.
62. [62] Irwin, R., Lin, H.V., Motyl, K.J., McCabe, L.R., Normal bone density obtained in the absence of insulin receptor expression in bone. Endocrinology 147 (2006), 5760–5767.
63. [63] Kanazawa, I., Osteocalcin as a hormone regulating glucose metabolism. World J. Diabetes 6 (2015), 1345–1354.
64. [64] Wei, J., Karsenty, G., An overview of the metabolic functions of osteocalcin. Rev. Endocr. Metab. Disord. 16 (2015), 93–98.
65. [65] Wedrychowicz, A., Stec, M., Sztefko, K., Starzyk, J.B., Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus. Experimental and clinical endocrinology & diabetes: official journal,German Society of Endocrinology [and] German Diabetes Association 122 (2014), 491–495.
66. [66] Maddaloni, E., D'Onofrio, L., Lauria, A., Maurizi, A.R., Strollo, R., Palermo, A., Napoli, N., Angeletti, S., Pozzilli, P., Manfrini, S., Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes. J. Endocrinol. Investig. 37 (2014), 661–666.
67. [67] Tsentidis, C., Gourgiotis, D., Kossiva, L., Doulgeraki, A., Marmarinos, A., Galli-Tsinopoulou, A., Karavanaki, K., Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporos. Int. 27 (2016), 1631–1643.
68. [68] Chrysis, D., Efthymiadou, A., Mermigka, A., Kritikou, D., Spiliotis, B.E., Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus. Pediatr. Diabetes, 2016.
69. [69] Faienza, M.F., Ventura, A., Delvecchio, M., Fusillo, A., Piacente, L., Aceto, G., Colaianni, G., Colucci, S., Cavallo, L., Grano, M., Brunetti, G., High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab., 2016 (jc20162371).
70. [70] Tsentidis, C., Gourgiotis, D., Kossiva, L., Marmarinos, A., Doulgeraki, A., Karavanaki, K., Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density. Pediatr. Diabetes 17 (2016), 289–299.
71. [71] Neumann, T., Hofbauer, L.C., Rauner, M., Lodes, S., Kastner, B., Franke, S., Kiehntopf, M., Lehmann, T., Muller, U.A., Wolf, G., Hamann, C., Samann, A., Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus. Clin. Endocrinol. 80 (2014), 649–655.
72. [72] Bener, A., Alsaied, A., Al-Ali, M., Al-Kubaisi, A., Basha, B., Abraham, A., Guiter, G., Mian, M., High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 46 (2009), 183–189.
73. [73] Ataie-Jafari, A., Rahmat, A.B., Abbasi, F., Cheong Loke, S., Qorbani, M., Larijani, B., Vitamin D status and associated factors in recent-onset type 1 diabetic children in Iran. Journal of diabetes and metabolic disorders, 11, 2012, 12.
74. [74] Bin-Abbas, B.S., Jabari, M.A., Issa, S.D., Al-Fares, A.H., Al-Muhsen, S., Vitamin D levels in Saudi children with type 1 diabetes. Saudi medical journal 32 (2011), 589–592.
75. [75] Greer, R.M., Portelli, S.L., Hung, B.S., Cleghorn, G.J., McMahon, S.K., Batch, J.A., Conwell, L.S., Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr. Diabetes 14 (2013), 31–41.
76. [76] Thnc, O., Cetinkaya, S., Kizilgun, M., Aycan, Z., Vitamin D status and insulin requirements in children and adolescent with type 1 diabetes. J. Pediatr. Endocrinol. Metab. 24 (2011), 1037–1041.
77. [77] Azab, S.F., Saleh, S.H., Elsaeed, W.F., Abdelsalam, S.M., Ali, A.A., Esh, A.M., Vitamin D status in diabetic Egyptian children and adolescents: a case-control study. Ital. J. Pediatr., 39, 2013, 73.
78. [78] Hamed, E.A., Faddan, N.H., Elhafeez, H.A., Sayed, D., Parathormone–25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 12 (2011), 536–546.
79. [79] Liu, Z., Kennedy, O.D., Cardoso, L., Basta-Pljakic, J., Partridge, N.C., Schaffler, M.B., Rosen, C.J., Yakar, S., DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH. FASEB J. 30 (2016), 635–652.
80. [80] DeBoer, M.D., Weber, D.R., Zemel, B.S., Denburg, M.R., Herskovitz, R., Long, J., Leonard, M.B., Bone mineral accrual is associated with parathyroid hormone and 1,25-dihydroxyvitamin D levels in children and adolescents. J. Clin. Endocrinol. Metab. 100 (2015), 3814–3821.
81. [81] Stagi, S., Cavalli, L., Ricci, S., Mola, M., Marchi, C., Seminara, S., Brandi, M.L., de Martino, M., Parathyroid hormone levels in healthy children and adolescents. Horm Res Paediatr 84 (2015), 124–129.
82. [82] McCabe, L.R., Understanding the pathology and mechanisms of type I diabetic bone loss. J. Cell. Biochem. 102 (2007), 1343–1357.
83. [83] Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S.P., Takahashi, K., Parfitt, A.M., Jilka, R.L., Manolagas, S.C., Lipschitz, D.A., Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 12 (1997), 1772–1779.
84. [84] Verma, S., Rajaratnam, J.H., Denton, J., Hoyland, J.A., Byers, R.J., Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55 (2002), 693–698.
85. [85] Abdalrahaman, N., McComb, C., Foster, J.E., McLean, J., Lindsay, R.S., McClure, J., McMillan, M., Drummond, R., Gordon, D., McKay, G.A., Shaikh, M.G., Perry, C.G., Ahmed, S.F., Deficits in trabecular bone microarchitecture in young women with type 1 diabetes mellitus. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 30 (2015), 1386–1393.
86. [86] Thomas, T., Gori, F., Khosla, S., Jensen, M.D., Burguera, B., Riggs, B.L., Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140 (1999), 1630–1638.
87. [87] Kirel, B., Dogruel, N., Korkmaz, U., Kilic, F.S., Ozdamar, K., Ucar, B., Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels. Clin. Biochem. 33 (2000), 475–480.
88. [88] Hanaki, K., Becker, D.J., Arslanian, S.A., Leptin before and after insulin therapy in children with new-onset type 1 diabetes. J. Clin. Endocrinol. Metab. 84 (1999), 1524–1526.
89. [89] Kiess, W., Anil, M., Blum, W.F., Englaro, P., Juul, A., Attanasio, A., Dotsch, J., Rascher, W., Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index. Eur. J. Endocrinol. 138 (1998), 501–509.
90. [90] Verrotti, A., Basciani, F., Morgese, G., Chiarelli, F., Leptin levels in non-obese and obese children and young adults with type 1 diabetes mellitus. Eur. J. Endocrinol. 139 (1998), 49–53.
91. [91] Luna, R., Garcia-Mayor, R.V., Lage, M., Andrade, M.A., Barreiro, J., Pombo, M., Dieguez, C., Casanueva, F.F., High serum leptin levels in children with type 1 diabetes mellitus: contribution of age, BMI, pubertal development and metabolic status. Clin. Endocrinol. 51 (1999), 603–610.
92. [92] Danne, T., Gruters, A., Wladimirova, A., Weber, B., Horn, R., Mayr, B., Brabant, G., Gender-specific differences of serum leptin in obese and normal-weight adolescents: studies in type-I diabetes and turner syndrome. Horm. Res. 48 (1997), 103–107.
93. [93] McCormick, K.L., Mick, G.J., Butterfield, L., Ross, H., Parton, E., Totka, J., Leptin in children with newly diagnosed type 1 diabetes: effect of insulin therapy. International journal of experimental diabetes research 2 (2001), 121–127.
94. [94] Bideci, A., Cinaz, P., Ezgu, F.S., Leptin levels in children with insulin dependent diabetes mellitus. Turk. J. Pediatr. 44 (2002), 211–214.
95. [95] Soliman, A.T., Omar, M., Assem, H.M., Nasr, I.S., Rizk, M.M., El Matary, W., El Alaily, R.K., Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metab. Clin. Exp. 51 (2002), 292–296.
96. [96] Ahmed, M.L., Ong, K.K., Watts, A.P., Morrell, D.J., Preece, M.A., Dunger, D.B., Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J. Clin. Endocrinol. Metab. 86 (2001), 1188–1193.
97. [97] Hathout, E.H., Sharkey, J., Racine, M., Ahn, D., Mace, J.W., Saad, M.F., Changes in plasma leptin during the treatment of diabetic ketoacidosis. J. Clin. Endocrinol. Metab. 84 (1999), 4545–4548.
98. [98] Fluck, C.E., Kuhlmann, B.V., Mullis, P.E., Insulin increases serum leptin concentrations in children and adolescents with newly diagnosed type I diabetes mellitus with and without ketoacidosis. Diabetologia 42 (1999), 1067–1070.
99. [99] Kamoda, T., Saitoh, H., Nakahara, S., Izumi, I., Hirano, T., Matsui, A., Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin. Endocrinol. 49 (1998), 385–389.
100. [100] Snell-Bergeon, J.K., West, N.A., Mayer-Davis, E.J., Liese, A.D., Marcovina, S.M., D'Agostino, R.B. Jr., Hamman, R.F., Dabelea, D., Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH case-control study. J. Clin. Endocrinol. Metab. 95 (2010), 2868–2876.
101. [101] Scholin, A., Siegbahn, A., Lind, L., Berne, C., Sundkvist, G., Bjork, E., Karlsson, F.A., CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes. Diabetes Metab. Res. Rev. 20 (2004), 205–210.
102. [102] Gomes, M.B., Piccirillo, L.J., Nogueira, V.G., Matos, H.J., Acute-phase proteins among patients with type 1 diabetes. Diabete Metab. 29 (2003), 405–411.
103. [103] Wedrychowicz, A., Dziatkowiak, H., Sztefko, K., Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 112 (2004), 435–439.
104. [104] Soedamah-Muthu, S.S., Chaturvedi, N., Pickup, J.C., Fuller, J.H., Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB prospective complications study (PCS). Diabetologia 51 (2008), 493–501.
105. [105] AboElAsrar, M.A., Elbarbary, N.S., Elshennawy, D.E., Omar, A.M., Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density. Cytokine 59 (2012), 86–93.
106. [106] Erbagci, A.B., Tarakcioglu, M., Coskun, Y., Sivasli, E., Sibel Namiduru, E., Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin. Biochem. 34 (2001), 645–650.
107. [107] Dogan, Y., Akarsu, S., Ustundag, B., Yilmaz, E., Gurgoze, M.K., Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediat. Inflamm., 2006, 2006, 59206.
108. [108] Devaraj, S., Glaser, N., Griffen, S., Wang-Polagruto, J., Miguelino, E., Jialal, I., Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55 (2006), 774–779.
109. [109] Locatto, M.E., Abranzon, H., Caferra, D., Fernandez, M.C., Alloatti, R., Puche, R.C., Growth and development of bone mass in untreated alloxan diabetic rats. Effects of collagen glycosylation and parathyroid activity on bone turnover. Bone Miner 23 (1993), 129–144.
110. [110] Kume, S., Kato, S., Yamagishi, S., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M., Nagata, K., Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J. Bone Miner. Res. 20 (2005), 1647–1658.
111. [111] Katayama, Y., Akatsu, T., Yamamoto, M., Kugai, N., Nagata, N., Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J. Bone Miner. Res. 11 (1996), 931–937.
112. [112] Botolin, S., McCabe, L.R., Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J. Cell. Biochem. 99 (2006), 411–424.
113. [113] Zayzafoon, M., Botolin, S., McCabe, L.R., P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J. Biol. Chem. 277 (2002), 37212–37218.
114. [114] Brandao-Burch, A., Utting, J.C., Orriss, I.R., Arnett, T.R., Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif. Tissue Int. 77 (2005), 167–174.
115. [115] Jivani, S.K., Rayner, P.H., Does control influence the growth of diabetic children?. Arch. Dis. Child. 48 (1973), 109–115.
116. [116] Thon, A., Heinze, E., Feilen, K.D., Holl, R.W., Schmidt, H., Koletzko, S., Wendel, U., Nothjunge, J., Development of height and weight in children with diabetes mellitus: report on two prospective multicentre studies, one cross-sectional, one longitudinal. Eur. J. Pediatr. 151 (1992), 258–262.
117. [117] Gunczler, P., Lanes, R., Esaa, S., Paoli, M., Effect of glycemic control on the growth velocity and several metabolic parameters of conventionally treated children with insulin dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 9 (1996), 569–575.
118. [118] Danne, T., Kordonouri, O., Enders, I., Weber, B., Factors influencing height and weight development in children with diabetes. Results of the berlin retinopathy study. Diabetes Care 20 (1997), 281–285.
119. [119] Holl, R.W., Grabert, M., Heinze, E., Sorgo, W., Debatin, K.M., Age at onset and long-term metabolic control affect height in type-1 diabetes mellitus. Eur. J. Pediatr. 157 (1998), 972–977.
120. [120] Elamin, A., Hussein, O., Tuvemo, T., Growth, puberty, and final height in children with type 1 diabetes. J. Diabetes Complicat. 20 (2006), 252–256.
121. [121] Tattersall, R.B., Pyke, D.A., Growth in diabetic children. Studies in identical twins. Lancet 2 (1973), 1105–1109.
122. [122] Leslie, R.D., Lo, S., Millward, B.A., Honour, J., Pyke, D.A., Decreased growth velocity before IDDM onset. Diabetes 40 (1991), 211–216.
123. [123] Chiarelli, F., Giannini, C., Mohn, A., Growth, growth factors and diabetes. Eur. J. Endocrinol. 151:Suppl. 3 (2004), U109–U117.
124. [124] Kanumakala, S., Dabadghao, P., Carlin, J.B., Vidmar, S., Cameron, F.J., Linear growth and height outcomes in children with early onset type 1 diabetes mellitus–a 10-yr longitudinal study. Pediatr. Diabetes 3 (2002), 189–193.
125. [125] Demir, K., Altincik, A., Abaci, A., Buyukgebiz, A., Bober, E., Growth of children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2 (2010), 72–77.
126. [126] Lebl, J., Schober, E., Zidek, T., Baldis, S., Rami, B., Pruhova, S., Kolouskova, S., Snajderova, M., Frisch, H., Growth data in large series of 587 children and adolescents with type 1 diabetes mellitus. Endocr. Regul. 37 (2003), 153–161.
127. [127] Huang, C.Y., Lee, Y.J., Huang, F.Y., Hsu, C.H., Kao, H.A., Final height of children with type 1 diabetes: the effects of age at diagnosis, metabolic control, and parental height. Acta Paediatr. Taiwan. 42 (2001), 33–38.